Grown Rogue International (GRUSF) Short-term Investments (2009 - 2025)

Grown Rogue International's (GRUSF) quarterly Short-term Investments came in at $5677.2 billion in Q3 2025, up 161507731.41% quarter-over-quarter from $3.5 million in Q2 2025.

Grown Rogue International (GRUSF) Short-term Investments (2009 - 2025) Analysis & Trends

Grown Rogue International's Short-term Investments history runs 7 years deep, the most recent figure standing at $5677.2 billion for Q3 2025.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $5677.2 billion in Q3 2025; TTM through Sep 2025 was $5677.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $4855.8 billion, changed N/A from the prior year.
  • Short-term Investments climbed to $5677.2 billion in Q3 2025 per GRUSF's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $5677.2 billion in Q3 2025 and bottomed at $2.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 5,677.23 Bn
Jun 30, 2025 3.52 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 4,855.80 Bn
Aug 31, 2015 25,899.36
May 31, 2015 25,182.52
May 31, 2012 924,808.96
Feb 29, 2012 456,776.33
Nov 30, 2011 488,440.76
Aug 31, 2011 9.16 Mn
May 31, 2011 8.17 Mn
Feb 28, 2011 7.74 Mn
Nov 30, 2010 7.17 Mn
Aug 31, 2010 5.48 Mn
Aug 31, 2009 90,377.16